Table of Contents Author Guidelines Submit a Manuscript
Clinical Study
Journal of Ophthalmology
Volume 2018, Article ID 9171269, 2 pages
https://doi.org/10.1155/2018/9171269
Corrigendum

Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab”

1Ophthalmology Department, Lille Catholic Hospitals, Lille Catholic University, Lille, France
2Clinique de la Louvière, Lille, France
3Centre Ophtalmologique de l’Odéon, Université Paris-Est Créteil (UPEC), Paris, France

Correspondence should be addressed to Thi Ha Chau Tran; ten.lcihg@uahcah.nart

Received 24 April 2018; Accepted 27 May 2018; Published 8 July 2018

Copyright © 2018 Thi Ha Chau Tran et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In the article titled “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” [1], there were errors, which should be corrected as follows:(i)In Abstract, the term “(DEP)” should be “(PED).”(ii)In Results, “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 91 µm, NS; M12: 312 ± 84 µm, NS; M24: 312 ± 12.3, NS)” should be corrected to “Change of CRT did not reach the significant difference at any time point of the study (M6: 312 ± 14 µm, NS; M12: 313 ± 13.9 µm, NS; M24: 305 ± 76, NS).”(iii)In Table 2, there were errors in the values in the third, fourth, and sixth columns. The corrected table and its description are shown below.